Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04302740 · ClinicalTrials.gov registry record · NA

Life Enhancing Alcohol-management Program

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
161
Enrollment target

NCT04302740 is a NA study that has completed, run by University of Washington. The registered enrollment target is 161 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04302740, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
161 participants
Enrollment target

Study Summary

People experiencing chronic homelessness comprise a small yet high-morbidity, high-cost subset of the larger homeless population and are disproportionately impacted by alcohol-related harm. Unfortunately, traditional abstinence-based treatment does not adequately reach or engage this population, and both firsthand (problems stemming from one's own alcohol use) and secondhand (problems stemming from others' alcohol use) alcohol-related harm persists even after housing attainment. There have therefore been calls for more flexible and client-centered approaches tailored to this population's needs. Housing First, which entails the provision of immediate, permanent, low-barrier, nonabstinence-based housing, is a response to this call. Research has shown that Housing First is associated with decreased alcohol use, alcohol-related harm, and publicly funded service utilization. Nonetheless, Housing First residents continue to experience both first- and secondhand alcohol-related harm. Thus, further community-based interventions are necessary. To this end, a pilot project was conducted in which researchers as well as Housing First residents, staff and management codeveloped, implemented, and initially evaluated the Life Enhancing Alcohol-management Program (LEAP). The LEAP entails low-barrier, community-level, house-wide resident programming-including leadership opportunities, activities, and pathways to recovery. At the 6-month follow up, LEAP participants reported significantly more engagement in meaningful activities than control participants (p \< .001). Moreover, high levels of LEAP program engagement (\>2 activities per month) predicted significant reductions in alcohol use and alcohol-related harm (ps \< .01). To build on these promising findings, we propose a larger, cluster-randomized controlled trial of LEAP (N=160) as an innovative, community-based, and client-driven adjunct to Housing First. Analyses will test LEAP effectiveness in increasing engagement in meanin

Interventions

  • BEHAVIORAL LEAP

Trial Details

FieldValue
Enrollment Target 161 participants
Start Date 2020-02-21
Est. Completion 2024-09-13
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT04302740

The ClinicalTrials.gov registry entry for NCT04302740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which LEAP is the first listed.

NCT04302740 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04302740 about?

NCT04302740 is a clinical study titled "Life Enhancing Alcohol-management Program". People experiencing chronic homelessness comprise a small yet high-morbidity, high-cost subset of the larger homeless population and are disproportionately impacted by alcohol-related harm. Unfortunately, traditional abstinence-based treatment does not adequately reach or engage this population, and...

What is the current status of trial NCT04302740?

This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2020-02-21. Estimated completion is 2024-09-13.

What interventions are being tested in trial NCT04302740?

The interventions under investigation include: LEAP (BEHAVIORAL).

Who is sponsoring clinical trial NCT04302740?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.